Indiana’s medical device workforce will need skills upgrade
A new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more than a high school education.
Health Care & Insurance
Articles
Gender bias suit filed against Quest Diagnostics
The $100 million lawsuit was brought in U.S. District Court by sales managers Erin Beery in Indianapolis and Heather Traeger in Bradenton, Fla., two employees of the company's AmeriPath division.
Lilly’s Zyprexa pact with health providers wins approval
Eli Lilly and Co. has won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper marketing of the company's best-selling medication, Zyprexa, raised their costs.
St. Vincent growing hospitalist program
Local health system adds Logansport to its list of clients.
Rating doctors and other health care providers
A new onslaught of Medicare data might shine more light on providers, but tricky questions abound.
Once-rising star AIT Laboratories now cutting jobs
AIT Laboratories, one of the area’s fastest-growing companies in recent years, confirmed Tuesday that it is eliminating jobs, but would not say how many. The company said it is restructuring.
Drugmaker plans 234 Terre Haute jobs by 2016
A California-based pharmaceutical company says it expects to hire 234 people by 2016 at a new operation on the site of a former Pfizer Inc. drug plant near Terre Haute.
Scrutiny rises on Bankers Life
After the insurer's name went on Indianapolis' downtown arena, CBS News focused on how hundreds of Bankers Life’s long-term-care insurance policyholders have accused the company of having “beat them down with bureaucracy."
Pressure rises as Lilly tries squeeze play
Indianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire, even as the company needs to spend more money on marketing and research to boost sales of new drugs.
Boston lawsuit claims DES-breast cancer link
Fifty-three women from around the country are suing drug companies, including Eli Lilly and Co., who made and promoted DES for millions of pregnant women from about 1938 to the early 1970s.
Healthx receives $22M capital infusion
Frontier Capital in Charlotte, N.C., provided the funding that will support the continued expansion of Healthx, a local provider of online health care portals.
Lilly challenging Biogen patent in London lawsuit
Eli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system diseases.
WellPoint, other insurers profit from health law they oppose
Insurance companies spent millions of dollars trying to defeat the U.S. health-care overhaul. But profit margins at the companies have widened to levels not seen since before the recession, a Bloomberg Government study shows.
Lilly’s 2012 earnings forecast misses analyst estimates
Indianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a wide margin, sending shares down.
IU doc growth slower than expected
Indiana University Health Physicians started as the Indiana Clinic three years ago with plans to employ at least 1,200 physicians by now. That hasn’t happened, but the organization said it won’t stop folding doctors into its organization.
Shareholders gives earful to BASI execs
For the first time in three years, Bioanalytical Systems Inc. boosted its annual revenue. But instead of receiving congratulations, one of the company’s largest shareholders said the company’s trends are “bleak.”
Walgreen expects to lose most Express Scripts biz
Drugstore operator Walgreen Co. said Thursday it expects to lose almost 90 percent of prescriptions handled by pharmacy benefits manager Express Scripts Inc. after it leaves Express Scripts' networks on Jan. 1.
WellPoint prevails in shareholder suit over 2001 restructuring
A federal judge has dismissed a shareholder class-action lawsuit against WellPoint stemming from the company’s 2001 conversion from a mutual insurer to a publicly traded company.
Filing: Roche considered leaving Indy
It’s hard to believe now, but as recently as two years ago, Indianapolis was close to losing its 15th-largest employer. Roche Diagnostics Corp. was looking seriously at moving its 2,900-employee North American headquarters out of Indianapolis.
Q&A
Dr. Bryan Schneider, a professor at the Indiana University School of Medicine, led a team of researchers in identifying genetic variations that dispose some breast cancer patients to neuropathy when they are receiving chemotherapy with the drug Taxol. Schneider’s research was named one of the biggest advances in cancer research this year by the American Society of Clinical Oncology. The society’s foundation also gave Schneider a three-year, $450,000 grant to further the research.